FFCP PHASE1:Mm9::chr12:40974757..40974783,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=3|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:40974757..40974783,+|id=chr12:40974757..40974783,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,2.64e-15,9|ontology_enrichment_disease=DOID:0060100!1.10e-15!3;DOID:4045!1.10e-15!3;DOID:0050686!1.62e-13!6|ontology_enrichment_disease_v019_2=DOID:0060100,4.58e-44,3;DOID:4045,4.58e-44,3;DOID:0050686,1.60e-22,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.64e-15,9;UBERON:0002036,2.64e-15,9;UBERON:0002385,2.64e-15,9;UBERON:0000486,2.64e-15,9;UBERON:0007503,2.64e-15,9;UBERON:0001015,2.64e-15,9;UBERON:0002329,2.64e-15,9;UBERON:0003082,2.64e-15,9;UBERON:0003059,2.64e-15,9;UBERON:0007282,2.64e-15,9;UBERON:0004290,2.64e-15,9;UBERON:0009618,2.64e-15,9;UBERON:0000383,7.43e-14,10;UBERON:0007524,1.14e-12,11;UBERON:0003077,1.14e-12,11;UBERON:0007285,1.14e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0.61506478758457,0,0,0,0,8.37063261473815,5.4693474116666,3.14114246384279,3.52938892818609,8.19654581950135,5.34061388334269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.253359865475099,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.508280908292259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215567992932842,0,0,0,0,0,0,0,0,0.51469581422943,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0.169978429993855,0.139951452323658,0.276399947608848,0,0,0,0,0,0,0,0,0,0.129614973291793,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:40974757..40974783,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:40974757..40974783,+ | |||
|description=CAGE_peak_at_chr12:40974757..40974783,+ | |||
|id=chr12:40974757..40974783,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.64e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!1.10e-15!3;DOID:4045!1.10e-15!3;DOID:0050686!1.62e-13!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.58e-44,3;DOID:4045,4.58e-44,3;DOID:0050686,1.60e-22,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.64e-15,9;UBERON:0002036,2.64e-15,9;UBERON:0002385,2.64e-15,9;UBERON:0000486,2.64e-15,9;UBERON:0007503,2.64e-15,9;UBERON:0001015,2.64e-15,9;UBERON:0002329,2.64e-15,9;UBERON:0003082,2.64e-15,9;UBERON:0003059,2.64e-15,9;UBERON:0007282,2.64e-15,9;UBERON:0004290,2.64e-15,9;UBERON:0009618,2.64e-15,9;UBERON:0000383,7.43e-14,10;UBERON:0007524,1.14e-12,11;UBERON:0003077,1.14e-12,11;UBERON:0007285,1.14e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198581902401771,0,0,0,0,0,0,0,0,0,0,0.61506478758457,0,0,0,0,8.37063261473815,5.4693474116666,3.14114246384279,3.52938892818609,8.19654581950135,5.34061388334269,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.253359865475099,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.508280908292259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215567992932842,0,0,0,0,0,0,0,0,0.51469581422943,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0.169978429993855,0.139951452323658,0.276399947608848,0,0,0,0,0,0,0,0,0,0.129614973291793,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:40974757..40974783,+ | |||
}} |
Latest revision as of 01:11, 5 August 2015
Short description: | p@chr12:40974757..40974783, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:40974757..40974783, + |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.64e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.64e-15 | 9 |
striated muscle tissue | 2.64e-15 | 9 |
muscle tissue | 2.64e-15 | 9 |
multilaminar epithelium | 2.64e-15 | 9 |
epithelial vesicle | 2.64e-15 | 9 |
musculature | 2.64e-15 | 9 |
somite | 2.64e-15 | 9 |
myotome | 2.64e-15 | 9 |
presomitic mesoderm | 2.64e-15 | 9 |
presumptive segmental plate | 2.64e-15 | 9 |
dermomyotome | 2.64e-15 | 9 |
trunk paraxial mesoderm | 2.64e-15 | 9 |
musculature of body | 7.43e-14 | 10 |
dense mesenchyme tissue | 1.14e-12 | 11 |
paraxial mesoderm | 1.14e-12 | 11 |
presumptive paraxial mesoderm | 1.14e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.58e-44 | 3 |
muscle cancer | 4.58e-44 | 3 |
organ system cancer | 1.60e-22 | 6 |